Are you Dr. Lee?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 34 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
10 Center Drive, Bldg10
Room12n226
Rockville, MD 20814Phone+1 301-443-7735Fax+1 212-932-5258- Is this information wrong?
Summary
- Dr. Jung-Min Lee, MD is an oncologist in Rockville, Maryland. She is currently licensed to practice medicine in New York.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2008 - 2012
Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Internal Medicine, 2003 - 2006
Certifications & Licensure
NY State Medical License 2007 - 2026- American Board of Internal Medicine Medical Oncology
Clinical Trials
Publications & Presentations
PubMed
- The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial.Elena Giudice, Tzu-Ting Huang, Jayakumar R Nair, Grant Zurcher, Ann McCoy, Darryl Nousome, Marc R Radke, Elizabeth M Swisher, Stanley Lipkowitz, Kristen Ibanez, Duncan...> ;Nature Communications. 2024 Mar 30
- 1 citationsAKT1 interacts with DHX9 to Mitigate R Loop-Induced Replication Stress in Ovarian Cancer.Tzu-Ting Huang, Chih-Yuan Chiang, Jayakumar R Nair, Kelli M Wilson, Ken Cheng, Jung-Min Lee> ;Cancer Research. 2024 Mar 15
- PARP inhibitors in ovarian cancer.Guidice, E., Goldlust, I., Lee, J.> ;Seminars in Oncology. 2024 Jan 14
- Join now to see all
Press Mentions
Pembrolizumab Improves Survival in Advanced Triple-Negative Breast CancerAugust 9th, 2022- The Power of Shared Purpose: Transforming Gynecologic Cancer CareMarch 26th, 2024
